You are using an outdated browser. Please upgrade your browser to improve your experience.
mitochondrial DNA depletion syndrome
Disease Summary
Associated Targets (21)
Tbio
16
Tchem
4
Tclin
1
GARD Rare
Mondo Description The mitochondrial DNA (mtDNA) depletion syndrome (MDS) is a clinically heterogeneous group of mitochondrial disorders characterized by a reduction of the mtDNA copy number in affected tissues without mutations or rearrangements in the mtDNA. MDS is phenotypically heterogeneous, and can affect a specific organ or a combination of organs, with the main presentations described being either hepatocerebral (i.e. hepatic dysfunction, psychomotor delay), myopathic (i.e. hypotonia, muscle weakness, bulbar weakness), encephalomyopathic (i.e. hypotonia, muscle weakness, psychomotor delay) or neurogastrointestinal (i.e gastrointestinal dysmotility, peripheral neuropathy). Additional phenotypes include fatal infantile lactic acidosis with methylmalonic aciduria, spastic ataxia (early-onset spastic ataxia-neuropathy syndrome), and Alpers syndrome.
Mondo Term and Equivalent IDs
MONDO:0018158: mitochondrial DNA depletion syndrome
Download Data for mitochondrial DNA depletion syndrome
data still loading...
Counts of Target Development Levels for diseases known to be associated with this disease. If the disease has a valid DOID, targets known to be associated with all child diseases are aggregated. Click "Explore Associated Targets" to view more facets and details for the target list.
This disease has been annotated by GARD as a rare disease.
Description from Mondo Disease Ontology.
DataSources which have contributed target associations to this disease, and the identifiers by which the disease is referenced.
DC:0000284
DOID:0070329
OMIMPS:603041
Orphanet:35698
UMLS:CN239350
MONDO:0018158
High level summary of knowledge for a disease, including descriptions and datasource references.